Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D
Qinheng Zheng, Ziyang Zhang, Keelan Z. Guiley, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1114-1122
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 994-1017
Open Access | Times Cited: 74
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
Tonia Kirschner, Matthias Müller, Daniel Rauh
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6044-6051
Closed Access | Times Cited: 9
Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket
Johannes Morstein, Vickie Bowcut, Micah C. Fernando, et al.
Cell (2024)
Open Access | Times Cited: 9
Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Covalent drug – An emerging framework for targeted drug development
Ritesh Bhole, Govinda O. Joshi, Harshad S. Kapare, et al.
Results in Chemistry (2024) Vol. 8, pp. 101615-101615
Open Access | Times Cited: 5
Pathways and mechanism of MRTX1133 binding to KRAS G12D elucidated by molecular dynamics simulations and Markov state models
Gao Tu, Yaguo Gong, Xiaojun Yao, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133374-133374
Closed Access | Times Cited: 5
Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set
Yu-Hong Tan, Mayukh Chakrabarti, Reed M. Stein, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Iden-tify Covalent TLCD1 Inhibitors
Hayden A. Sharma, Michael Bielecki, Meredith A. Holm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting KRASG13C: Exploring Warhead Orientation with Cyclic Linker-Based Inhibitors
Tonia Kirschner, J. M. Rodríguez, Emerson G. Moreira, et al.
Research Square (Research Square) (2025)
Closed Access
Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
Proteome-wide Ligand and Target Discovery by Using Strain-Enabled Cyclopropane Electrophiles
Yue Liu, Zhongtang Yu, Peishan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 30, pp. 20823-20836
Closed Access | Times Cited: 4
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets
Kilian Colas, Daniel Bindl, Hiroaki Suga
Chemical Reviews (2024) Vol. 124, Iss. 21, pp. 12213-12241
Open Access | Times Cited: 4
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
Mirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117830-117830
Closed Access | Times Cited: 3
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics
Giulia Alboreggia, Parima Udompholkul, Emma L. Atienza, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20214-20223
Open Access | Times Cited: 3
Another KRAS variant trapped
Kenneth D. Westover
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1096-1097
Closed Access | Times Cited: 2
ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
Nathan L. Tran, Jiewei Jiang, Min Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96
Randa Mahran, Jonas N. Kapp, Salla Valtonen, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 10, pp. 2152-2164
Closed Access | Times Cited: 2
Ligand discovery by activity-based protein profiling
Micah J. Niphakis, Benjamin F. Cravatt
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1636-1651
Closed Access | Times Cited: 2
Malolactone strikes: K-Ras-G12D's Achilles' heel
Christos Adamopoulos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 472-474
Closed Access | Times Cited: 1
Natural Product Graveoline Modulates Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Membrane Association: Insights from Advanced Spectroscopic Studies
Gabriel Cornilescu, Lakshman Bindu, Louise M. Sternicki, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 1983-1995
Closed Access | Times Cited: 1
Targeting active RAS with molecular glue
Wenjing Su, Xuben Hou
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100047-100047
Open Access | Times Cited: 1
Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer
Eszter Molnár, Marcell Baranyi, Krisztina Andrea Szigeti, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
Chemical Dissection of Selective Myeloid Leukemia-1 Inhibitors: How They Were Found and Evolved
Lianzhou Wang, Yuxiang Chen, MeiZhi Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117168-117168
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top